0001213900-23-027445.txt : 20230405 0001213900-23-027445.hdr.sgml : 20230405 20230405130749 ACCESSION NUMBER: 0001213900-23-027445 CONFORMED SUBMISSION TYPE: AW PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20230405 DATE AS OF CHANGE: 20230405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN MEDICAL INC CENTRAL INDEX KEY: 0000840551 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: AW SEC ACT: SEC FILE NUMBER: 333-267447 FILM NUMBER: 23801889 BUSINESS ADDRESS: STREET 1: 155 UNIVERSITY AVENUE, SUITE 750 CITY: TORONTO STATE: A6 ZIP: M5H 3B7 BUSINESS PHONE: 416-548-7522 X153 MAIL ADDRESS: STREET 1: 155 UNIVERSITY AVENUE, SUITE 750 CITY: TORONTO STATE: A6 ZIP: M5H 3B7 AW 1 ea176526-aw_titanmedical.htm AMENDMENT WITHDRAWAL

	Jasminder Brar
	Vice President, Legal & IP, & General Counsel
	Titan Medical Inc.
April 4, 2023
	416.628.6875 Direct
	Jasminder.brar@titanmedicalinc.com

Via EDGAR

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

USA

Re:

Titan Medical Inc.

Request to Withdraw Post-Effective Amendment to Form S-8

(File No. 333-267447)

Ladies and Gentlemen:

Pursuant to Rule 477 of the Securities Act of 1933, as amended (the “Securities Act”), Titan Medical Inc. (the “Company”) hereby requests withdrawal of its Post-Effective Amendment No. 1 to Registration Statement on Form S-8 (File No. 333-267447), together with all exhibits and amendments thereto (the “Registration Statement”), as the Registration Statement was filed with the Securities and Exchange Commission (the “Commission”) in an incorrect manner. The Registration Statement was originally filed with the Commission on September 16, 2022 and was filed on a post-effective basis on April 4, 2023.

If you have any questions with respect to this request, please contact James Guttman, our outside counsel at Dorsey & Whitney LLP at (416) 367-7376 or the undersigned at (416) 628-6875.

Sincerely,

TITAN MEDICAL INC.

By	/s/ Jasminder Brar
	Name:	Jasminder Brar
	Title:	Vice President, Legal & IP, & General Counsel

GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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